1.
Tsuzuki S, Yasuda T, Goto H, Maeda N, Akahane K, Inukai T, Yamamoto H, Karnan S, Ota A, Hyodo T, Konishi H, Hosokawa Y, Kiyoi H, Hayakawa F. BCL6 inhibition ameliorates resistance to ruxolitinib in <i>CRLF2</i&gt;-rearranged acute lymphoblastic leukemia. haematol [Internet]. 2023Feb.1 [cited 2024Mar.29];108(2):394-08. Available from: https://haematologica.org/article/view/haematol.2022.280879